Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
作者信息
Elam M B, Cushman W, Applegate W B, Heimberg M
机构信息
Department of Pharmacology, University of Tennessee Health Science Center, USA.
出版信息
Tenn Med. 1997 May;90(5):189-92.
PMID:9130876
Abstract
摘要
相似文献
1
2
Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).苏格兰西部冠心病预防研究（WOSCOPS）的重叠分析。
Circulation. 1999 Aug 10;100(6):686.
3
[Statins in primary prevention of coronary heart disease].[他汀类药物在冠心病一级预防中的应用]
Wien Med Wochenschr. 1999;149(5-6):129-38.
4
[Primary and secondary prevention of coronary disease by statins].他汀类药物对冠心病的一级和二级预防
Ann Cardiol Angeiol (Paris). 1999 Feb;48(2):128-36.
5
[The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].[4S研究——胆固醇争论的转折点。瑞士心脏病学会脂质与动脉粥样硬化工作组]
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1514-6.
6
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中，与其他他汀类药物相比，瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇（LDL-C）水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
7
Statins prevent coronary heart disease.他汀类药物可预防冠心病。
Lancet. 1995 Nov 25;346(8987):1378-9. doi: 10.1016/s0140-6736(95)92399-3.
8
[Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].[辛伐他汀治疗中重度高胆固醇血症患者的有效性和耐受性。一项为期12个月的研究结果]
Minerva Cardioangiol. 1993 Mar;41(3):105-9.
9
Statin therapy in clinical practice: new developments.临床实践中的他汀类药物治疗：新进展
Curr Opin Lipidol. 1995 Oct;6(5):254-5.
10
[A new study on hypercholesterolemia. Statin is effective against heart disease].[一项关于高胆固醇血症的新研究。他汀类药物对心脏病有效]
Lakartidningen. 1996 May 29;93(22):2131-3.
Zotero 插件